Evidence map›Paper›PMID 40536816›Full record

ArticleBriefings in bioinformatics2025

PrimeNet: rational design of Prime editing pegRNAs by deep learning.

Xichen Liao, Qi Liu, Guohui Chuai

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xichen LiaoDepartment of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, Bioinformatics Department, School of Life Sciences and Technology, Tongji University, No. 1239 Siping Road, Yangpu District, Shanghai 200092, China.
Qi LiuDepartment of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, Bioinformatics Department, School of Life Sciences and Technology, Tongji University, No. 1239 Siping Road, Yangpu District, Shanghai 200092, China.
Guohui ChuaiDepartment of Hematology, Tongji Hospital, Frontier Science Center for Stem Cell Research, Bioinformatics Department, School of Life Sciences and Technology, Tongji University, No. 1239 Siping Road, Yangpu District, Shanghai 200092, China.

Funding

Fundamental Research Funds for the Central UniversitiesNational Key Research and Development Program of China 2021YFF1200900National Key Research and Development Program of China 2021YFF1201200National Natural Science Foundation of China 32341008National Natural Science Foundation of China 62002265National Natural Science Foundation of China T24250193Shanghai Excellent Academic Leader ProjectShanghai Municipal Science and Technology Major Project 2021SHZDZX0100Shanghai Pilot Program for Basic ResearchShanghai Science and Technology Innovation Action Plan-Key Specialization in Computational BiologyShanghai Shuguang Scholars ProjectTongji University "Medicine + X" Cross Research Program 2025080107
6 · The paper itself

Abstract

The rapid development of gene editing technology has revolutionized life science research and biotechnology applications. Prime editing, a precise gene editing tool, has shown promise in various applications, including disease research and therapeutic interventions. However, its suboptimal editing efficiency for extensive fragments and lack of predictive models have hindered its widespread adoption. Existing models exhibit low prediction accuracy and limitations, such as neglecting epigenetic factors that impact gene editing effects. To address these challenges, we developed PrimeNet, a novel prediction model that integrates significant epigenetic factors, including chromatin accessibility and DNA methylation. By incorporating data from multiple cell lines and introducing multiscale convolution and attention mechanisms, PrimeNet enhances the accuracy of predictions and generalization performance. Our results show that PrimeNet achieves a Spearman correlation coefficient of 0.94 and 0.82 on two datasets originated from HEK293T and K562 cell lines, respectively, outperforming existing models. This novel model has the potential to guide experimental design, enhance the success rate of gene editing, and reduce unnecessary experimental costs, thereby advancing the application of gene editing technology in genetic disease treatment and related fields.

Indexed as

Deep LearningGene EditingCRISPR-Cas SystemsDNA MethylationEpigenesis, GeneticHEK293 CellsHumansK562 CellsCRISPRdeep learningepigeneticsgene editingmachine learningPrime editing

Identifiers

PMID40536816
PMCPMC12204610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.